
Elevance Health Inc (ELV), Pathward Financial Inc (CASH), and UMB Financial Corp (UMBF) are scheduled to trade ex-dividend on September 10, 2025, with their respective quarterly payouts expected to result in corresponding share price adjustments. ELV's $1.71 dividend implies a 0.55% price reduction, CASH's $0.05 a 0.07% reduction, and UMBF's $0.40 a 0.32% reduction, all else being equal. Notably, Elevance Health is identified as a 'future dividend aristocrats contender' due to its consistent dividend growth spanning over 14 years, signaling potential long-term income stability for investors.
Elevance Health (ELV), Pathward Financial (CASH), and UMB Financial (UMBF) are set to trade ex-dividend on September 10, 2025, triggering predictable, minor adjustments in their share prices. Elevance Health's quarterly dividend of $1.71 translates to a 2.18% annualized yield, the highest of the trio, and is accompanied by a strong performance signal, with shares recently trading up 1.8%. Critically, ELV is highlighted as a 'future dividend aristocrats contender' due to its consistent dividend growth for over 14 years, signaling a robust and reliable capital return policy. In contrast, Pathward Financial offers a minimal 0.26% annualized yield, and its shares were recently down 2.5%, reflected in its negative per-ticker sentiment. UMB Financial offers a moderate 1.29% annualized yield with a slight 0.7% share price increase. The key takeaway is the differentiation in dividend profiles: ELV presents a compelling dividend growth story, whereas CASH's dividend appears nominal, and UMBF's is moderate, underscoring the importance of examining historical consistency and yield as part of due diligence.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment